GSK to invest $800M for new R&D, manufacturing hub in Pennsylvania
GSK has budgeted more than $800 million to grow its Pennsylvania footprint, its second expansion in the state in two years. The company will begin construction in 2027 at its current site ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.